Replies to post #2272 on Vitro Diagnostics Inc (fka VODG)

[JonesBur]

Even though many companies are ISO certified, this does show that they continue to take the steps to becoming a legitimate company. This also suggests the ramp up is real, so all good things indeed. Based on this, becoming up to date with officially reporting financials might be one of the last steps needed, which I fully expect in the next 4-5 months. With this, they should start to convince an increasing number of people. Which with the increased exposure lately has come an increasing number of people questioning them.

[Potse]

VODG(.175)...possible R&D development.....

Picked up a few more shares a couple of weeks ago for a possible trading pop/spike soon (see link below). This 20-cent area continues to look interesting to me as we wait for the FY 2018 press release. Just have a hunch/feeling there is going to be a pretty big tradeable move in the share price shortly after that PR is issued.

By the way, the stock I mentioned at the end of the below post is now trading at a fully-diluted valuation of $656M (7.29B shares x 9 cents/shr).....

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145931810

One thing I definitely want to see in this press release is a detailed/positive update and commentary on the filing delinquency situation. I know this sounds like a broken record, but I can't stress enough how important this is. I'm sure I am not the only investor who will be making adjustments to my position size in the first half of 2019 if management doesn't convey a sense of urgency regarding the filing delinquency.

Here is one thing that could turn into an interesting catalyst: It is possible (and I stress the word "possible") that VODG is currently modifying its stem cells for use in spinal fluid. The husband of one of the Vitro Biopharma patients in New Zealand made an update post on January 7 (2 weeks ago) regarding some future developments in her treatment for 2019.

He does not mention if these new stem cells will be coming from VODG or if another company is involved. If it turns out that these new cells are in fact coming from Vitro Biopharma, things could get extremely interesting here........

No one knows how much of the previous treatments were able to cross the blood brain barrier. Some must have crossed the barrier because Jackie experienced some benefit. For the best results the stem cells need to be put where the problem is. In Jackie's case putting the stem cells in the cerebella is not possible because of the dangers associated.

Presently putting stem cell in the the spinal/brain fluid is not advised due to undesirable side effects.

Now there is work being done to modify the stem Cells so they won't cause side effecs if introduced in to the spinal fluid. The reasoning is that since the brain is bathed in the spinal fluid stem cels will surely will have access to the ailing cerebella.

Presently these cells are not available but are expected later this year.

When they become available I would like your help to give Jackie treatment with this new cells.

I will keep you updated when they become available.

https://givealittle.co.nz/cause/jackies-msa-cerebella-treatment/updates